Selling The Skinny

Selling The Skinny

For three years straight, I have written on these pages about patent-related issues involving the defining drugs of our lifetimes, GLP-1’s. Let’s go for the fourth year in a row. In 2023, I focused on recently granted patents that the two behemoths in the weight-loss...